CBD Co. Zynerba, Investors Seek OK For $4M Settlement Deal
Investors in CBD drugmaker Zynerba Pharmaceuticals have asked a federal judge in Pennsylvania to approve a $4 million settlement deal that would end claims that the company withheld unfavorable information about...To view the full article, register now.
Already a subscriber? Click here to view full article